Aurora Cannabis Inc. (NASDAQ:ACB - Free Report) - Equities research analysts at Roth Capital issued their Q3 2025 EPS estimates for Aurora Cannabis in a research report issued to clients and investors on Wednesday, November 6th. Roth Capital analyst W. Kirk forecasts that the company will post earnings of $0.21 per share for the quarter. The consensus estimate for Aurora Cannabis' current full-year earnings is ($0.37) per share. Roth Capital also issued estimates for Aurora Cannabis' Q4 2025 earnings at $0.40 EPS.
Aurora Cannabis Price Performance
Shares of ACB stock traded down $0.05 on Monday, reaching $4.77. The company had a trading volume of 818,531 shares, compared to its average volume of 3,078,763. The stock has a market capitalization of $261.59 million, a PE ratio of -6.34 and a beta of 1.87. The company has a quick ratio of 2.03, a current ratio of 3.76 and a debt-to-equity ratio of 0.08. Aurora Cannabis has a one year low of $2.84 and a one year high of $9.35. The business's 50-day moving average is $5.64 and its 200 day moving average is $5.96.
Hedge Funds Weigh In On Aurora Cannabis
Institutional investors and hedge funds have recently modified their holdings of the business. Virtu Financial LLC purchased a new stake in Aurora Cannabis during the first quarter worth about $727,000. TD Asset Management Inc purchased a new stake in Aurora Cannabis in the second quarter worth $255,000. Headlands Technologies LLC bought a new stake in shares of Aurora Cannabis in the first quarter valued at $166,000. Mackenzie Financial Corp purchased a new position in shares of Aurora Cannabis during the 2nd quarter valued at $113,000. Finally, Concurrent Investment Advisors LLC bought a new stake in Aurora Cannabis in the 1st quarter valued at about $90,000. 47.63% of the stock is currently owned by institutional investors.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Stories
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
